Development of small molecular probes for the molecular imaging of apoptosis

Anti-Cancer Agents in Medicinal Chemistry

Volumn 9, Issue 9, 2009, Pages 986-995

  Wenbin, Zeng ^a   Weimin, Miao ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell death; Imaging; Probe; Small molecular

Indexed keywords

(5 DIMETHYLAMINO) 1 NAPHTHALENE SULFONYL ALPHA ETHYL FLUOROALANINE; 1 [4 [2 FLUOROTHOXY] BENZYL] 5 (2 PHENOXYMETHYL PYRROLIDINE 1 SULFONYL) 1H INDOLE 2,3 DIONE; 5 [1 [2 METHOXYMETHYL PYRROLIDINE]SULFONYL]ISATIN; 7 AMINO 4 METHYLCOUMARIN; 7 AMINO 4 METHYLCOUMARIN DERIVATIVE; AMINOLUCIFERIN; APOSENSE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BIOLOGICAL MARKER; CASPASE; CASPASE INHIBITOR; CHEMICAL COMPOUND; COUMARIN DERIVATIVE; CYBATE 1; CYBATE 2; DANSYL CHLORIDE; DYE; FLUORESCENT DYE; GADOLINIUM; IODINE 131; ISATIN; ISATIN DERIVATIVE; N,N' DIDANSYL CYSTINE; NST 732; PACLITAXEL; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE; SYNAPTOTAGMIN I; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL DAMAGE; CELL STRUCTURE; DEVELOPMENT; DNA FRAGMENTATION; DRUG STRUCTURE; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; MOLECULAR IMAGING; NONHUMAN; PATHOGENESIS; REVIEW; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; CYSTEINE PROTEINASE INHIBITORS; FLUORESCENT DYES; HUMANS; MOLECULAR PROBES; SUBSTRATE SPECIFICITY;

EID: 73449084045     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152009789377763     Document Type: Review

References (80)

1. Hayashi, T.; Abe, K. Ischemic neuronal cell death and organellae damage. Neurol. Res., 2004, 26, 827-834.
2. Prunell, G. F.; Arboleda, V. A.; Troy, C. M. Caspase function in neuronal death: delineation of the role of caspases in ischemia. Curr. Drug Targets CNS Neurol. Disord., 2005, 4, 51-61.
3. Gu, Z.; Cui, J.; Brown, A.; Fridman, R.; Mobashery, S.; Strongin, A. Y.; Lipton, S. A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apotosis in transient focal cerebral ischemia. J. Neurosci., 2005, 25, 6401-6408.
4. Abbate, A.; Bussani, R.; Biondi Zoccai, G. G.; Santini, D.; Petrolini, A.; de Giorgio, F.; Vasaturo, F.; Scarpa, S.; Severino, A.; Liuzzo, G.; Leone, A. M.; Baldi, F.; Sinagra, G.; Silvestri, F.; Vetrovec, G. W.; Crea, F.; Biasucci, L. M.; Baldi, A. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur. Heart J., 2005, 26, 2039-2045.
5. Hartmann, A.; Hunot, S.; Michel, Patrick P.; Muriel, M.; Vyas, S.; Faucheux, B.; Mouatt A.; Turmel, H.; Srinivasan, A.; Ruberg, M.; Evan, G.; Agid, Y.; Hirsch, E. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2000, 97, 2875-2880.
6. Marx, J. Neuroscience: new leads on the 'how' of Alzheimer's. Science, 2001, 293, 2192-2194.
7. Blankenberg, F.G.; Katsikis, P.D.; Trait, J.F.; Davis, R.E.; Naumovski, L.; Ohtsuki, K.; Kopiwoda, S.; Abrams, M. J.; Darkes, M.; Robbins, R.C.; Maecker, H.T.; Strauss, H. W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA, 1998, 95, 6349-6354.
8. Petrovsky, A.; Schellenberger, E.; Josephson, L.; Weissleder, R.; Bogdanov, A. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res., 2003, 63, 1936-1942.
9. Laborte, C.M.; Vanderheyden, J. L.; Steinmetz, N.; Van de Wiele, C.; Dierckx, R. A.; Slegers, G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31, 887-919.
10. Boersma, H. H.; Kietselaer, B. L.; Stolk, L. M.; Bennaghmouch, A.; Hofstra, L.; Narula, J.; Heidendal, G. A.; Reutelingsperger, C. P. Past, present, and future of Annexin A5: from protein discovery to clinical application. J. Nucl. Med., 2005, 46, 2035-2050.
11. Fink, S. L.; Cookson, B. T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun., 2005, 73, 1907-1916.
12. Zeng, W.; Miao, W.; Kabalka, G.; Le Puil, M.; Biggerstaff, D.; Townsend, D. Design, synthesis, and biological evaluation of a dansyled amino acid derivative as an imaging agent for apoptosis. Tetrahedron Lett., 2008, 49, 6429-6433.
13. Kim, K.; Lee, M.; Park, H.; Kim, J.; Kim, S.; Chung, H.; Choi, K.; Kim, I.; Seong, B.; Kwon, I. Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J. Am. Chem. Soc., 2006, 128, 3490-3491.
14. Herman, S. Mechanisms and genes of celular suicide. Science, 1995, 267, 1445-1449.
15. Kerr, J. F.; Wyllie, A. H.; Currie, A. R. Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 1972, 26, 239-257.
16. Arends, M. J.; Morris, R. G.; Wyllie, A. H. Apoptosis: The role of endonuclease. Am. J. Pathol., 1990, 136, 593-608.
17. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 1980, 284, 555-556.
18. Watanabe, M.; Hitomi, M.; Van der Wee, K.; Rothenberg, F.; Fisher, S. A.; Zucker, R. M.; Svoboda, K. K.; Goldsmith, E. C.; Heiskanen, K. M.; Nieminen, A. L. The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc. Microanal., 2002, 8, 375-391.
19. Otsuki, Y. ; Li, Z. ; Shibata, M. A. Apoptotic detection methods - from morphology to gene. Prog. Histochem. Cytochem., 2003, 38, 275-339.
20. Hakumaeki, J. M.; Liimatainen, T. Molecular imaging of apoptosis in cancer. Eur. J. Radiol., 2005, 56, 143-153.
21. Blankenberg, F. G. ; Tait, F. F.; Strauss, H. W. Apoptotic cell death: its implications for imaging in the next millennium. Eur. J. Nucl. Med., 2000, 27, 359-367.
22. Bremer, C.; Ntziachristos, V.; Weissleder, R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur. Radiol., 2003, 13, 231-243.
23. Czaronota, G. J.; Kolios, M. C.; Abraham, J.; Portnov, M.; Ottensmeyer, F. P.; Hunt, J. W.; Sherar, M. D. Ultrasound imaging of apoptosis: high resolution non-invasive monitoring of programmed cell death in vitro, in situ, and in vivo. Br. J. Cancer, 1999, 81, 520-527.
24. Otsuki, Y. ; Li, Z. ; Shibata, M.A. Apoptotic detection methods - from morphology to gene. Prog. Histochem. Cytochem., 2003, 38, 275-339.
25. Weissleder, R.; Moore, A.; Mahmood, U.; Bhorade, R.; Benveniste, H.; Chiocca, E.; Basilion, J. B. In vivo MR imaging of transgene expression. Nat. Med., 2000, 6, 351-355.
26. Artemov, D. Molecular magnetic resonance imaging with targeted contrast agents. J. Cell Biochem., 2003, 90, 518-524.
27. Klymchenko, A. S.; Stoeckel, H.; Takeda, K.; Mely, Y. Fluorescent probe based on intramolecular proton transfer for fast ratiometric measurement of cellular transmembrane potential. J. Phys. Chem. B, 2006, 110, 13624-13632.
28. Klymchenoko, A. S.; Duportail, G.; Mely, Y.; Demchenko, A. P. Ultrasensitive two-color fluorescence probes for dipole potential in phospholipid membranes. Proc. Natl. Acad. Sci. USA, 2003, 100, 11219-11224.
29. Klymchenko, A. S.; Demchenko, A. P. Electrochromic modulation of excited-state intramolecular proton transfer: the new principle in design of fluorescence sensors. J. Am. Chem. Soc., 2002, 124, 12372-12379.
30. Shynkar, V. V.; Klymchenko, A. S.; Kunzelmann, C.; Duportail, G.; Muller, C. D.; Demchenko, A. P.; Freyssinet, J.; Mely, Y. Fluorescent biomembrane probe for ratiometric detection of apoptosis. J. Am. Chem. Soc., 2007, 129, 2187-2193.
31. Bleackley, C.; Heibein, J. A. Enzymatic control of apoptosis. Nat. Prod. Rep., 2001, 18, 431-440.
32. Lahorte, C. M.; Vanderheyden, J. L.; Steinmetz, N.; Van de Wiele, C.; Dierckx, R. A.; Slegers, G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur. Nucl. Med. Mol. Imaging, 2004, 31, 887-919.
33. Talanian, R.V.; Brady, K. D.; Cryns, V. L. Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery. J. Med. Chem., 2000, 43, 3351-3371.
34. Reed, J. C.; Tomaselli, K. J. Drug discovery opportunities from apoptosis research. Curr. Opin. Biotechnol., 2000, 11, 586-592.
35. Haberkorn, U.; Kinscherf, R.; Krammer, P. H.; Mier, W.; Eisenhut, M. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(o-methyl)-fluoromethylketone. Nucl. Med. Biol., 2001, 28, 793-798.
36. Fischer, U.; Jaenicke, R. U.; Schulze-Osthoff, K. Many cuts to ruin:a comprehensive update of caspase substrates. Cell Death Differ., 2003, 10, 76-100.
37. 18F]-labeled α-trifluoromethyl ketones for PET imaging. J. Label. Compd. Radiopharm., 2003, 46, S189.
38. Thornberry, N. A.; Rano, T. A.; Peterson, E. P.; Rasper, D. M.; Timkey, T.; Garcia-Calvo, M.; Houtzager, V. M.; Nordstrom, P. A.; Roy, S.; Vaillancourt, J. P.; Chapman, K. T.; Nicholson, D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 1997, 272, 17907-17911.
39. Haberkorn, U.; Kinscherf, R.; Krammer, P. H.; Mier, W.; Eisenhut, M. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone. Nucl. Med. Biol., 2001, 28, 793-798.
40. 131I-Labeled peptides as caspase substrates for apoptosis imaging. J. Nucl. Med., 2005, 46, 1066-1074.
41. Wang, Y.; Huang, J.C.; Zhou, Z. L.; Yang, W.; Guastella, J.; Drewe, J.; Cai, S. X. Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid. Bioorg. Med. Chem. Lett., 2004, 14, 1269-1272.
42. Garcia-Calvo, M.; Peterson, E. P.; Leiting, B.; Ruel, R.; Nicholson, D. W.; Thornberry, N. A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem., 1998, 273, 32608-32613.
43. Liu, J.; Bhalgat, M.; Zhang, C.; Diwu, Z.; Hoyland, B.; Klaubert, D. H. Fluorescent molecular probes. V. A sensitive caspase-3 substrate for fluorometric assays. Bioorg. Med. Chem. Lett., 1999, 9, 3231-3236.
44. Cai, S. X.; Zhang, H.; Guastella, J.; Drewe, J.; Yang, W.; Weber, E. Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg. Med. Chem. Lett., 2001, 11, 39-42.
45. Wang, Z. Q.; Liao, J.; Diwu, Z. N-DEVD-N′- morpholinecarbonylrhodamine 110: novel caspase-3 fluorogenic substrates for cell-based apoptosis assay. Bioorg. Med. Chem. Lett., 2005, 15, 2335-2338.
46. O'Brien, M. A.; Daily, W. J.; Hesselberth, P. E.; Moravec, R. A.; Scurria, M. A.; Kalubert, D. H.; Bulleit, R. E.; Wodd, K. V. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J. Biomol. Screen, 2005, 10, 137-148.
47. Bullok, K.; Piwnica-Worms, D. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J. Med. Chem., 2005, 48, 5404-5407.
48. Hotchkiss, R. S.; McConnell, K. W.; Bullok, K.; Davis, C. G.; Chang, K. C.; Schwulst, S. J.; Dunne, J. C.; Dietz, G. P.; Baehr, M.; McDunn, J. E.; Karl, I. E.; Wagner, T. H.; Cobb, J. P.; Coopersmith, C. M.; Piwnica-Worms, D. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J. Immunol., 2006, 176, 5471-5477.
49. Maxwell, D.; Chang, D.; Zhang, X.; Barnett, E. M.; Piwnica-Worms, D. An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug. Chem., 2009, 20, 702-709.
50. Zhang, Z.; Fan, J.; Cheney, P. P.; Berezin, M. Y.; Edwards, W. B.; Akers, W. J.; Shen, D.; Liang, K.; Culver, J. P.; Achilefu, S. Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. Mol. Pharm., 2009, 6, 416.
51. Zhao, M.; Zhu, X.; Ji, S.; Zhou, J.; Ozker, K. S.; Fang, W.; Molthen, R. C.; Hellman, R. S. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J. Nucl. Med., 2006, 47, 1367-1374.
52. Jung, H. I.; Kettunen M. I.; Daveletoc, B.; Brindle, K. M. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug. Chem., 2004, 15, 983-987.
53. Fang, W.; Wang, F.; Ji, S.; Zhu, X.; Meier, H. T.; Hellman, R. S.; Brindle K. M.; Davletov, B.; Zhao, M. SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model. Nucl. Med. Chem., 2007, 34, 917-923.
54. Zhu, X.; Li, Z.; Zhao, M. Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion. J. Nucl. Med., 2007, 48, 1031-1036.
55. Zhao, M.; Li, Z.; Bugenhagen, S. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J. Nucl. Med., 2008, 49, 1345-1352.
56. Wang, F.; Fang, W.; Zhao, M.; Wang, Z.; Ji, S.; Li, Y.; Zheng, Y. Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study. Nucl. Med. Biol., 2008, 35, 359-364.
57. Kimura, E.; Aoki, S.; Kikuta, E.; Koike, T. A macrocyclic Zinc (II) fluorophore as a detector of apoptosis. Proc. Natl. Acad. Sci. USA, 2003, 100, 3731-3736.
58. Koike, T.; Watanabe, T.; Aoki, S.; Kimura, E.; Shiro, M. A novel biomemetic zinc(II)-fluorophore, dansylaminoethyl-pendant macrocyclic tetraamine 1,4,7,10-tetrazacyclododecane (Cyclen). J. Am. Chem. Soc., 1996, 118, 12696-12703.
59. 2+. Inorg. Chem., 2008, 47, 2747-2754.
60. Aloya, R.; Grimberg, H.; Reshef, A.; Levin, G.; Kidron, D.; Cohen, A.; Ziv, I. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis, 2006, 11, 2089-2101.
61. Damianovich, M.; Ziv, I.; Heyman, S. N.; Rosen, S.; Shina, A.; Kidron, D.; Aloya, T.; Grimberg, H.; Levin, G.; Reshef, A.; Bentolila, A.; Cohen, A.; Shirvan, A. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur. J. Nucl. Med. Mol. Imaging, 2006, 33, 281-291.
62. Reshef, A.; Shirvan, A.; Grimberg, H.; Levin, G.; Cohen, A.; Mayk, A.; Kidron, D.; Djaidetti, R.; Melamed, E.; Ziv, I. Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res., 2007, 144, 156-164.
63. Reshef, A.; Shirvan, A.; Waterhouse, R.N.; Grimberg, H.; Levin, G.; Cohen, A.; Ulysse, L.G.; Friedman, G.; Antoni, G.; Ziv, I. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J. Nucl. Med., 2008, 49, 1520-1528.
64. Cohen, A.; Ziv, I.; Aloya, T.; Levin, G.; Kidron, D.; Grimberg, H.; Reshef, A.; Shirvan, A. Monitoring of chemotherapy-induced cell death in melanoma tumors by N,N′-Didansyl-L-cystine. Technol. Cancer Res. Treat., 2007, 6, 221-234.
65. Reshef, A.; Shirvan, A.; Shohami, E.; Grimberg, H.; Levin, G.; Cohen, A.; Trembovler, V.; Ziv, I. Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J. Neurotrauma, 2008, 25, 569-580.
66. Zeng, W.; Yao, M.; Townsend, D.; Kabalka, G.; Wall, J.; Le Puil, M.; Biggerstaff, J.; Miao, W. Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis. Bioorg. Med. Chem. Lett., 2008, 18, 3573-3577.
67. Zeng, W.; Townsend, D.; Kabalka, G.; Wall, J.; Miao, W. Biological evaluation of dansylhydrazone derivatives for cancer cell apoptosis imaging. J. Nucl. Med., 2008, 49, S351.
68. Zeng, W.; Yao, Townsend, D.; Kabalka, G.; Wall, J.; Le Puil M.; Biggerstaff, J.; Miao, W. Synthesis and biological evaluation of (E)-5-(dimethylamino)-N′-(4-fluoro -benzylidene)-naphthalene-1- sulfono-hydrazone as an agent for imaging apoptosis. J. Nucl. Med., 2008, 49, S294.
69. Loevqvist, A.; Sundin, A.; Ahlstroem, H.; Carlsson, J.; Lundqvist, H. Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody. J. Nucl. Med., 1997, 38, 395-401.
70. Kabalka, G.; Mereddy, M.; Green, J. The no-carrier-added synthesis of bromine-76 labeled alkenyl and alkynyl bromides using organotrifluoroborates. J. Label. Compd. Radiopharm., 2006, 49, 11-15.
71. Schoenberger, J.; Bauer, J.; Moosbauer, J.; Eilles, C.; Grimm, D. Innovative strategies in in vivo apoptosis imaging. Curr. Med. Chem., 2008, 15, 187-194.
72. Porter, A.G.; Jaenicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ., 1999, 6, 99-104.
73. Kopka, K.; Faust, A.; Keul, P.; Wagner, S.; Breyholz, H. J.; Hoeltke, C.; Schober, O.; Schaefers, M.; Levkau, B. 5-Pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis. J. Med. Chem., 2006, 49, 6704-6715.
74. Podichetty, A. K.; Wagner, S.; Schroeer, S.; Faust, A. Schäfers, M.; Schober, O.; Kopka, K.; Haufe, G. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis. J. Med. Chem., 2009, 52, 3484-3495.
75. Podichetty, A. K.; Faust, A.; Kopka, K.; Wagner, S.; Schober, O.; Schaefers, M.; Haufe, G. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors. Bioorg. Med. Chem., 2009, 17, 2680-2688.
76. Chu, W.; Zhang, J.; Zeng, C.; Rothfuss, J.; Tu, Z.; Chu, Y.; Reichert, D.E.; Welch, M.J.; Mach, R.H. N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies. J. Med. Chem., 2005, 48, 7637-7647.
77. Zhou D.; Chu, W.; Rothfuss, J.; Zeng, C.; Xu, J.; Jones, L.; Welch, M.J.; Mach, R.H. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg. Med. Chem. Lett., 2006, 16, 5041-5046.
78. Zhou, D.; Chu, W.; Chen, D.; Wang, Q. ; Reichert, D. E.; Rothfuss, J.; D'Avignon, A.; Welch, M.; Mach, R. H. [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Org. Biomol. Chem., 2009, 7, 1337-1348.
79. 18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q. J. Nucl. Med. Mol. Imaging., 2007, 51, 67-73.
80. Smith, G.; Glaser, M.; Perumal, M.; Nguyen, Q.; Shan, B.; Arstad, E.; Aboagye, E. O. Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide. J. Med. Chem., 2008, 51, 8057-8067.